GRI BIO, INC. (GRI) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$1.65M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$2.00M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$3.37M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$2.90M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | Reported | (m) | -$1.65M | (m) | (m) | (m) | (m) | -$1.45M* | (m) | $407.00K | (m) | (m) |
| 2026-03-31 | Reported | (m) | -$2.00M | (m) | (m) | (m) | (m) | -$3.69M | (m) | $361.00K | (m) | (m) |
| 2025-09-30 | Reported | (m) | -$3.37M | (m) | (m) | (m) | (m) | -$2.31M* | (m) | $1.77M | (m) | (m) |
| 2025-06-30 | Reported | (m) | -$2.90M | (m) | (m) | (m) | (m) | -$3.17M* | (m) | $1.88M | (m) | (m) |
| 2025-03-31 | Reported | (m) | -$3.05M | (m) | (m) | (m) | (m) | -$1.74M | (m) | $1.64M | (m) | (m) |
| 2024-09-30 | Reported | (m) | -$2.13M | (m) | (m) | (m) | $0.00* | -$2.27M* | (m) | $1.13M | (m) | (m) |
| 2024-06-30 | Reported | (m) | -$2.26M | (m) | (m) | (m) | (m) | -$2.14M* | (m) | $877.00K | (m) | (m) |
| 2024-03-31 | Reported | (m) | -$1.90M | (m) | (m) | (m) | (m) | -$2.20M | (m) | $933.00K | (m) | (m) |
| 2023-09-30 | Reported | (m) | -$2.44M | (m) | (m) | (m) | $0.00* | -$1.31M* | (m) | $1.19M | (m) | (m) |
| 2023-06-30 | Reported | (m) | -$5.93M | (m) | (m) | (m) | (m) | -$1.54M* | (m) | $880.00K | (m) | (m) |
| 2023-03-31 | Reported | (m) | -$988.00K | (m) | (m) | (m) | (m) | -$579.00K | (m) | $116.00K | (m) | (m) |
| 2022-09-30 | Reported | (m) | -$186.00K | (m) | (m) | (m) | $0.00* | -$125.00K* | (m) | $63.00K | (m) | (m) |
| 2022-06-30 | Reported | (m) | -$189.00K | (m) | (m) | (m) | (m) | $2.17M* | (m) | $59.00K | (m) | (m) |
| 2022-03-31 | Reported | (m) | -$2.63M | (m) | $0.00 | (m) | (m) | -$2.29M | (m) | $1.27M | (m) | (m) |
| 2021-09-30 | Reported | (m) | -$1.25M | (m) | $0.00 | (m) | $0.00* | -$1.29M* | (m) | $215.00K | (m) | (m) |
| 2021-06-30 | Reported | (m) | -$2.31M | (m) | $0.00 | (m) | (m) | -$2.49M* | (m) | $1.20M | (m) | (m) |
| 2021-03-31 | Reported | (m) | -$2.60M | (m) | $0.00 | (m) | (m) | -$2.95M | (m) | $1.77M | $830.00K | $0.00 |
| 2020-09-30 | Reported | (m) | -$1.03M | (m) | $0.00 | (m) | $0.00* | -$1.06M* | (m) | $733.00K | (m) | (m) |
| 2020-06-30 | Reported | (m) | -$1.14M | (m) | $0.00 | (m) | $0.00* | -$1.07M* | (m) | $808.00K | (m) | (m) |
| 2020-03-31 | Reported | (m) | -$1.16M | (m) | $100.00K | (m) | $2.00K | -$766.00K | (m) | $883.00K | $375.00K | $0.00 |
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Reported | (m) | -$11.98M | (m) | (m) | (m) | $3.00K | -$10.19M | (m) | $6.82M | (m) | $3.00K |
| 2024-12-31 | Reported | (m) | -$8.23M | (m) | (m) | (m) | $0.00 | -$8.61M | (m) | $3.77M | (m) | $2.00K |
| 2023-12-31 | Reported | (m) | -$11.39M | (m) | (m) | (m) | $8.00K | -$8.99M | (m) | $3.23M | (m) | (m) |
| 2022-12-31 | Reported | (m) | -$2.24M | (m) | (m) | (m) | $3.00K | -$1.08M | (m) | $242.00K | (m) | (m) |
| 2021-12-31 | Reported | (m) | -$9.26M | (m) | $0.00 | (m) | $0.00 | -$8.31M | (m) | $5.19M | (m) | (m) |
| 2020-12-31 | Reported | (m) | -$4.79M | (m) | $100.00K | (m) | $2.00K | -$3.71M | (m) | $3.71M | (m) | (m) |